EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Hurdle or thruster: Glucose metabolism of T cells in anti-tumour immunity

Sirui Zhang, Xiaozhen Zhang, Hanshen Yang, Tingbo Liang, Xueli Bai

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2024-01 · 1879 (1) · 189022

DOI: 10.1016/j.bbcan.2023.189022 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2024-01. Verfasst von Sirui Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, Zhejiang…. Hauptthemen laut MEDLINE: T-Lymphocytes, Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 132 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Fundamental Research Funds for the Provincial Universities of Zhejiang, Key Research and Development Program of Zhejiang Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glucose metabolism is essential for the activation, differentiation and function of T cells and proper glucose metabolism is required to maintain effective T cell immunity. Dysregulation of glucose metabolism is a hallmark of cancer, and the tumour microenvironment (TME2) can create metabolic barriers in T cells that inhibit their anti-tumour immune function. Targeting glucose metabolism is a promising approach to improve the capacity of T cells in the TME. The efficacy of common immunotherapies, such as immune checkpoint inhibitors (ICIs3) and adoptive cell transfer (ACT4), can be limited by T-cell function, and the treatment itself can affect T-cell metabolism. Therefore, understanding the relationship between immunotherapy and T cell glucose metabolism helps to achieve more effective anti-tumour therapy. In this review, we provide an overview of T cell glucose metabolism and how T cell metabolic reprogramming in the TME regulates anti-tumour responses, briefly describe the metabolic patterns of T cells during ICI and ACT therapies, which suggest possible synergistic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

T-LymphocytesNeoplasmsHumansImmunotherapyImmunotherapy, AdoptiveGlucoseTumor Microenvironment

Stichwörter der Autor:innen

Adoptive cell transfer therapyGlucose metabolismImmune checkpointMetabolic reprogrammingT cellTumour microenvironment

Substanzen

Glucose

Autor:innen und Institutionen

  • Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, Zhejiang, China; Zhejiang Provincial Key Laboratory of Pancreatic Disease, the…

Förderung

  • Fundamental Research Funds for the Provincial Universities of Zhejiang
  • Key Research and Development Program of Zhejiang Province
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, S., Zhang, X., Yang, H., Liang, T., & Bai, X. (2024). Hurdle or thruster: Glucose metabolism of T cells in anti-tumour immunity. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1879(1), 189022. https://doi.org/10.1016/j.bbcan.2023.189022

Vancouver

Zhang S, Zhang X, Yang H, Liang T, Bai X. Hurdle or thruster: Glucose metabolism of T cells in anti-tumour immunity. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2024;1879(1):189022. doi:10.1016/j.bbcan.2023.189022

BibTeX
@article{Zhang2024,
  author = {Zhang, Sirui and Zhang, Xiaozhen and Yang, Hanshen and Liang, Tingbo and Bai, Xueli},
  title = {Hurdle or thruster: Glucose metabolism of T cells in anti-tumour immunity},
  journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
  year = {2024},
  volume = {1879},
  number = {1},
  pages = {189022},
  doi = {10.1016/j.bbcan.2023.189022}
}
Kostenlos starten →